Subscribe to RSS
DOI: 10.1055/s-0028-1088050
Synthesis of the Reported Protoberberine Gusanlung D
Publication History
Publication Date:
20 April 2009 (online)
Abstract
Starting from homopiperonylamine or phenethylamine with homophthalic anhydride or 3,4-methylenedioxyhomophthalic acid, respectively, facile syntheses of the reported structures of (±)-gusanlung D and (±)-isogusanlung D were accomplished via regioselective reductive dehydration of the corresponding homophthalimides followed by an intramolecular acid-catalyzed or radical cyclization pathway. Starting from the corresponding suitably ortho-halogenated homophthalimides, the syntheses of dehydrogusanlung and dehydroisogusanlung D were completed via regioselective reductive dehydration followed by an intramolecular Heck coupling reaction as the key steps. The analytical and spectral data obtained for all four synthetic compounds differed from the reported data for natural gusanlung D, and therefore the structural assignment of the natural product needs to be revised.
Key words
homophthalic anhydride, homopiperonyl amine - reductive dehydration - Heck reaction - gusanlung D
Protoberberine alkaloids make up an important class of natural products that contain a tetracyclic ring skeleton with an isoquinoline core [¹] possessing anti-inflammatory, antimicrobial, antileukemic, and antitumor activities. [²] Many elegant achiral and chiral synthetic routes to protoberberines have been reported in the literature. [²] [³] The isolation of (-)-gusanlung D (2,3-methylenedioxy-8-oxoberberine, 1; Scheme [¹] ) from the stem of Acangelisia gusanlung was reported in 1995 by Zhong et al.; this is the first optically active protoberberine unoxygenated at ring D. [4] Well before the isolation of gusanlung D, Kesser et al. from India reported its racemic synthesis via the generation and trapping of α-oxo-o-quinodimethanes. [5] Unfortunately, the analytical and spectral data reported for the natural and synthetic gusanlung D were not in agreement with one other. [4] [5] Padwa and Waterson reported a neat approach to berberine derivative (±)-1 by taking advantage of a Pummerer/Mannich-induced cyclization cascade. [6] Recently, Reimann et al. reported the synthesis of (±)-gusanlung D from the Reissert compounds. [7] Very recently, Chang and Chang reported the synthesis of (±)-gusanlung D via dehydrogusanlung D (2; Scheme [¹] ), by taking advantage of ring-closing metathesis. [8] Chrzanowska et al. reported the first asymmetric synthesis of both (+)- and (-)-gusanlung D, indicating the possibility of considerable contamination of the natural product with dehydrogusanlung D (2). [9]
During the past several years, we have been using cyclic anhydrides as potential precursors for the synthesis of structurally interesting and biologically important natural and unnatural products. [¹0] As the unconjugated carbonyl group in the homophthalic anhydride/imide can be regioselectively explored, we reasoned that homophthalic anhydride or imide would be the most appropriate building block for the synthesis of protoberberine alkaloids. Herein we report a general strategy for the synthesis of protoberberine alkaloids starting from homophthalic anhydride or imide, to synthesize the reported (±)-gusanlung D (1), (±)-isogusanlung D (3), dehydrogusanlung D (2), and dehydroisogusanlung D (4) by three different modes of intramolecular cyclization (Schemes [¹] and [²] ).
The regioselective ring opening of homophthalic anhydride (6) at the more reactive unconjugated carbonyl with homopiperonylamine (5) in a diethyl ether-tetrahydrofuran mixture at room temperature exclusively furnished benzoic acid 7 in 92% yield (Scheme [¹] ). An attempted preparation of the corresponding isoquinoline-1,3(2H,4H)-dione 9 by dehydration of 7 induced by acetic anhydride-sodium acetate resulted instead in the formation of 3-hydroxyisoquinolin-1(2H)-one 8 bearing an α-acyl substituent in 76% yield (Scheme [¹] ), formed due to the highly acidic nature of the α-methylene protons of such systems. A singlet signal at δ = 11.05 and the corresponding absence of a methylene proton signal in the ¹H NMR spectrum of the above product clearly revealed that the product existed exclusively as the enol 8, which is stabilized by conjugation of the double bond with the carbonyl group and the phenyl ring as well as by intramolecular hydrogen bonding. Ultimately, acid 7 on treatment with hexamethyldisilazane-zinc(II) chloride [¹¹] gave the desired isoquinoline-1,3(2H,4H)-dione 9 in 90% yield (Scheme [¹] ).

Scheme 1 Reagents and conditions: (i) Et2O-THF (4:1), r.t., 2 h (92%); (ii) Ac2O, NaOAc, 60 ˚C, 3 h (76%); (iii) HMDS, ZnCl2, benzene, 2.5 h (90%); (iv) (a) NaBH4, EtOH, 0 ˚C, 6 h; (b) H+/HCl, r.t., 12 h (72%); (v) concd HCl, r.t., 48 h (68%); (vi) I2, AgO2CCF3, CHCl3, r.t., 8 h (86%); (vii) (a) NaBH4, EtOH, 0 ˚C, 6 h; (b) H+/HCl, r.t., 12 h (78%); (viii) AIBN, Bu3SnH, benzene, reflux, 6 h (63%); (ix) Pd(OAc)2, tetramethylguanidine, NaOAc, DMF, 110 ˚C, 20 h (72%).

Scheme 2 Reagents and conditions: (i) Ph(CH2)2NH2 (for 14a) or 2-BrC6H4(CH2)2NH2 (for 14b), 1,2-dichlorobenzene, 180 ˚C, 3 h (92/94%); (ii) (a) NaBH4, EtOH, 0 ˚C, 6 h; (b) H+/HCl, r.t., 12 h (98%); (iii) AIBN, Bu3SnH, benzene, reflux, 2 h (80%); (iv) Pd(OAc)2, TBAB, K2CO3, DMF, 120 ˚C, 24 h (74%).
We envisaged a regioselective reduction of the unconjugated carbonyl in imide 9 to provide the corresponding hydroxylactam, which upon intramolecular cyclization would provide us with the desired racemic protoberberine (±)-1 (Scheme [¹] ). Interestingly, when we carried out the sodium borohydride reduction of 9 under the conditions reported by Speckamp et al., [¹²] the expected hydroxylactam formed as an intermediate, directly furnishing the isoquinolin-1(2H)-one 10 in 72% yield by an in situ dehydration. The formation of 10 constitutes a formal synthesis of (±)-gusanlung D (1), since 10 is a known precursor that can be easily transformed into the protoberberine, as demonstrated by Padwa and Waterson. [6] We employed their acid-catalyzed cyclization conditions to convert enamide 10 into (±)-gusanlung D (1) in 68% yield (Scheme [¹] ). However, the analytical and spectral data for compound 1 synthesized by us did not match those reported for the isolated natural product, but were in full agreement with those reported in the earlier syntheses. [5-9] Chrzanowska et al. had opined that the discrepancy could have arisen due to a possible contamination of the isolated natural product with a considerable amount of the corresponding oxidized product dehydrogusanlung D (2), [8] formed during the isolation process. Therefore, we planned to synthesize dehydrolactam 12 by a route that had the potential to deliver (±)-gusanlung D (1) as well.
Towards this end, a very selective iodination of imide 9 by iodine-silver trifluoroacetate was used, affording isoquinoline-1,3(2H,4H)-dione 11 in 86% yield (Scheme [¹] ). As expected, the sodium borohydride reduction of 11, under the Speckamp et al. conditions as before, furnished isoquinolin-1(2H)-one 12 in 78% yield. Compound 12 could potentially serve as a precursor to both (±)-gusanlung D (1), through an intramolecular radical cyclization, as well as dehydrogusanlung D (2), via an intramolecular Heck coupling reaction (Scheme [¹] ). [¹³] Unfortunately, our attempts at intramolecular radical cyclization of 12 using the standard conditions consisting of azoisobutyronitrile and tributyltin hydride failed to deliver the protoberberine (±)-1; we ended up instead with the dehalogenated product 10 in 63% yield (Scheme [¹] ). We were, nevertheless, successful in carrying out a palladium(II) acetate-tetramethylguanidine induced [¹4] intramolecular Heck coupling of isoquinolin-1(2H)-one 12, and obtained the desired dehydrogusanlung D (2) in 72% yield (Scheme [¹] ). The analytical and spectral data obtained for 2 were in complete agreement with the reported data. [8] However, a comparison of the analytical and spectral data of compound 2 with those of gusanlung D (1) and those reported for the isolated natural product ruled out the possibility that the isolated product could have been contaminated with a considerable amount of 2.
At this stage, on the basis of the ¹H NMR data for reported natural 1 (a singlet at δ = 7.35 for one of the aromatic protons), we felt that there is a possibility that the isolated natural product could be the isomeric compound 3 (peri interaction with the carbonyl group), and we planned to synthesize both (±)-isogusanlung D (3) and dehydroisogusanlung D (4) (Scheme [²] ). The thermal double dehydrative condensation of phenethylamine or 2-bromophenethylamine with 3,4-methylenedioxyhomophthalic acid 13 [¹5] gave the corresponding imides 14a and 14b, respectively, in high yields (Scheme [²] ). The regioselective reductive dehydration of both the imides 14a and 14b provided the required isoquinolinone derivatives 15a and 15b, respectively, in 98% yield. All our attempts to induce acid-catalyzed intramolecular cyclization of 15a to form (±)-isogusanlung D (3) met with failure, because of the absence of any activating group on phenyl ring, required to force such type of cyclizations. However, treatment of aryl bromide 15b with azoisobutyronitrile-tributyltin hydride resulted in intramolecular radical cyclization, [¹6] to furnish the desired (±)-isogusanlung D (3) in 74% yield, while Heck coupling of 15b gave the corresponding dehydroisogusanlung D (4) in 80% yield (Scheme [²] ). Unfortunately, in this case too, the obtained analytical and spectral data for 3 and 4 did not match the data reported for the natural product 1.
In summary, we have developed a general approach to protoberberine alkaloids starting from homophthalic anhydride, and accomplished a facile synthesis of the claimed gusanlung D and isogusanlung D via an efficient regioselective reductive dehydration followed by acid-catalyzed or radical-induced intramolecular cyclizations, respectively. Similarly, the synthesis of the corresponding dehydrogusanlung D and dehydroisogusanlung D were completed by taking advantage of an elegant intramolecular Heck coupling reaction. Unfortunately, the analytical and spectral data obtained for all four berberine analogues did not concur with the reported data of the natural product. At this point, we feel that revision of the reported structural assignment of gusanlung D needs to be undertaken, and that it would be more appropriate to re-establish the actual structure of the natural product gusanlung D on the basis of X-ray crystallographic analysis.
Melting points are uncorrected. ¹H NMR spectra of samples in CDCl3 and DMSO-d 6 with TMS as an internal standard were recorded on 200- and 400-MHz spectrometers. ¹³C NMR spectra were recorded on 200-, 400- and 500-MHz NMR spectrometers (at 50, 100, and 125 MHz, respectively, for ¹³C). IR spectra were recorded on an FT-IR spectrometer. Column chromatographic separations were done on silica gel (60-120, 230-300 mesh). Commercially available homophthalic anhydride (6), 2-bromophenethylamine, HMDS, ZnCl2, silver trifluoroacetate, Bu3SnH, and Pd(OAc)2 were used.
2-(2-{[2-(1,3-Benzodioxol-5-yl)ethyl]amino}-2-oxoethyl)benzoic Acid (7)
A soln of homopiperonylamine (5; 2.48 g, 15.00 mmol) in Et2O (15 mL) was added dropwise over 15 min to a constantly stirring soln of homophthalic anhydride (6; 2.43 g, 15.00 mmol) in a mixture of Et2O-THF (4:1, 15 mL). The reaction mixture was stirred for 2 h at r.t. and the precipitated crystalline product was filtered, washed with Et2O (30 mL), and dried in vacuo; this gave 7.
Yield: 4.52 g (92%); mp 155-157 ˚C (Lit. [¹7] 158-159 ˚C).
IR (CHCl3): 3346, 1700, 1694 cm-¹.
¹H NMR (200 MHz, DMSO-d 6): δ = 2.64 (t, J = 7 Hz, 2 H), 3.26 (q, J = 7 Hz, 2 H), 3.86 (s, 2 H), 5.97 (s, 2 H), 6.65 (dd, J = 8, 2 Hz, 1 H), 6.80 (s, 1 H), 6.82 (d, J = 10 Hz, 1 H), 7.26 (dd, J = 10, 2 Hz, 1 H), 7.36 (dt, J = 8, 2 Hz, 1 H), 7.49 (dt, J = 8, 2 Hz, 1 H), 7.86 (dd, J = 8, 2 Hz, 1 H), 7.98 (t, J = 6 Hz, 1 H).
¹³C NMR (50 MHz, DMSO-d 6): δ = 35.2, 40.8, 40.9, 100.9, 108.4, 109.4, 121.9, 127.0, 130.5, 131.6, 131.9 (2 C), 133.6, 137.2, 145.8, 147.5, 169.0, 170.5.
Anal. Calcd for C18H17NO5: C, 66.05; H, 5.23; N, 4.28. Found: C, 65.96; H, 5.11; N, 4.35.
4-Acetyl-2-[2-(1,3-benzodioxol-5-yl)ethyl]-3-hydroxyisoquinolin-1(2 H )-one (8)
A stirred mixture of 7 (490 mg, 1.50 mmol) in Ac2O (10 mL) and fused NaOAc (20 mg, 0.24 mmol) was heated at 60 ˚C for 3 h. The mixture was allowed to reach r.t. and was then poured into ice-cold H2O. The precipitate that formed was filtered, washed with an excess of H2O, and vacuum-dried; this gave 8.
Yield: 400 mg (76%); mp 112-114 ˚C.
IR (CHCl3): 3311, 1739, 1648 cm-¹.
¹H NMR (200 MHz, CDCl3): δ = 2.57 (s, 3 H), 2.88 (t, J = 7 Hz, 2 H), 3.73 (app q, J = 7 Hz, 2 H), 5.92 (s, 2 H), 6.60-6.80 (m, 3 H), 7.10-7.25 (m, 1 H), 7.50-7.70 (m, 2 H), 8.16 (d, J = 8 Hz, 1 H), 11.05 (bs, 1 H).
¹³C NMR (50 MHz, CDCl3): δ = 31.0, 35.5, 42.7, 92.4, 100.8, 108.2, 108.9, 114.8, 121.6, 123.3, 123.4, 130.2, 131.5, 134.8, 138.7, 146.2, 147.7, 158.6, 160.9, 194.2.
Anal. Calcd for C20H17NO5: C, 68.37; H, 4.88; N, 3.99. Found: C, 68.57; H, 4.93; N, 4.05.
2-[2-(1,3-Benzodioxol-5-yl)ethyl]isoquinoline-1,3(2 H ,4 H )-dione (9)
To a stirred suspension of 7 (3.92 g, 12.00 mmol) in anhyd benzene (30 mL) was added ZnCl2 (1.64 g, 12.00 mmol) and the mixture was heated at 80 ˚C. To this mixture was slowly added a soln of HMDS (3.75 mL, 18.00 mmol) in anhyd benzene (15 mL) over 20 min. The mixture was refluxed for an additional 2 h, then cooled to r.t. and poured into 1 N HCl (30 mL). The aqueous phase was extracted with EtOAc (3 × 30 mL) and the combined organic layer was washed with 5% aq NaHCO3 (3 × 20 mL) and brine (25 mL), and dried (Na2SO4). Concentration of the organic layer in vacuo followed by purification of the residue by column chromatography (silica gel, PE-EtOAc, 4:1) gave pure 9.
Yield: 3.34 g (90%); mp 158-159 ˚C (Lit. [¹7] 156-157 ˚C).
IR (CHCl3): 1709, 1662, 1607 cm-¹.
¹H NMR (200 MHz, CDCl3): δ = 2.75-2.90 (m, 2 H), 4.03 (s, 2 H), 4.05-4.25 (m, 2 H), 5.92 (s, 2 H), 6.65-6.85 (m, 3 H), 7.28 (d, J = 8 Hz, 1 H), 7.45 (t, J = 8 Hz, 1 H), 7.60 (dt, J = 8, 2 Hz, 1 H), 8.22 (d, J = 8 Hz, 1 H).
¹³C NMR (50 MHz, CDCl3): δ = 33.7, 36.3, 41.6, 100.7, 108.1, 109.3, 121.7, 125.2, 127.0, 127.6, 129.0, 132.2, 133.5, 134.0, 146.0, 147.5, 164.6, 169.7.
Anal. Calcd for C18H15NO4: C, 69.89; H, 4.89; N, 4.53. Found: C, 70.02; H, 4.81; N, 4.59.
2-[2-(1,3-Benzodioxol-5-yl)ethyl]isoquinolin-1(2 H )-one (10)
Excess NaBH4 (304 mg, 8.00 mmol) was added to a stirred soln of 9 (309 mg, 1.00 mmol) in EtOH (10 mL) at 0 ˚C. The mixture was stirred under inert atmosphere for 6 h at 0 ˚C while 2-3 drops of 2 N HCl in EtOH were added at intervals of 20 min. The excess of NaBH4 was then quenched at 0 ˚C by the addition of 2 N HCl in EtOH until the mixture was acidic (pH 3). The mixture was then allowed to warm to r.t. and stirred for a further 12 h. The EtOH was removed by distillation under reduced pressure, the residue was diluted with H2O (20 mL), and the mixture was extracted with EtOAc (3 × 25 mL). The combined organic layer was washed with H2O (20 mL), 5% aq NaHCO3 (20 mL), and brine (20 mL) and dried (Na2SO4). Concentration of the organic layer in vacuo followed by purification of the residue by column chromatography (silica gel, PE-EtOAc, 4:1) gave 10.
Yield: 211 mg (72%); mp 87-88 ˚C (Lit. [6] 90-91 ˚C).
IR (CHCl3): 1649, 1626 cm-¹.
¹H NMR (200 MHz, CDCl3): δ = 3.00 (t, J = 8 Hz, 2 H), 4.16 (t, J = 8 Hz, 2 H), 5.93 (s, 2 H), 6.39 (d, J = 8 Hz, 1 H), 6.60-6.75 (m, 3 H), 6.81 (d, J = 8 Hz, 1 H), 7.40-7.55 (m, 2 H), 7.55-7.70 (m, 1 H), 8.45 (d, J = 8 Hz, 1 H).
¹³C NMR (50 MHz, CDCl3): δ = 34.9, 51.6, 100.8, 105.6, 108.3, 109.2, 121.8, 125.8, 126.1, 126.6, 127.6, 131.9 (2 C), 132.0, 137.0, 146.2, 147.7, 161.9.
Anal. Calcd for C18H15NO3: C, 73.71; H, 5.15; N, 4.78. Found: C, 73.59; H, 5.22; N, 4.59.
2-[2-(6-Iodo-1,3-benzodioxol-5-yl)ethyl]isoquinoline-1,3(2 H ,4 H )-dione (11)
I2 (775 mg, 3.05 mmol) was added in small portions over 15 min to a stirring soln of 9 (943 mg, 3.05 mmol) and AgO2CCF3 (674 mg, 3.05 mmol) in anhyd CHCl3 (15 mL). The mixture was stirred for a further 8 h at r.t. The mixture was filtered, washed with CH2Cl2 (25 mL) and the filtrate was washed with 5% aq Na2S2O3 (10 mL), H2O (20 mL), and brine (25 mL) and dried (Na2SO4). Concentration of the organic layer in vacuo followed by purification of the residue by column chromatography (silica gel, PE-EtOAc, 4:1) gave 11.
Yield: 1.14 g (86%); mp 217-219 ˚C.
IR (CHCl3): 1701, 1668, 1609 cm-¹.
¹H NMR (200 MHz, CDCl3): δ = 2.90-3.10 (m, 2 H), 4.04 (s, 2 H), 4.10-4.25 (m, 2 H), 5.95 (s, 2 H), 6.85 (s, 1 H), 7.22 (s, 1 H), 7.25-7.35 (m, 1 H), 7.45 (t, J = 8 Hz, 1 H), 7.60 (dt, J = 8, 2 Hz, 1 H), 8.22 (dd, J = 8, 2 Hz, 1 H).
¹³C NMR (50 MHz, CDCl3): δ = 36.4, 38.6, 40.2, 87.7, 101.5, 109.7, 118.6, 125.3, 127.1, 127.7, 129.1, 133.6, 134.1, 135.0, 147.2, 148.5, 164.7, 169.8.
Anal. Calcd for C18H14INO4: C, 49.68; H, 3.24; N, 3.22. Found: C, 49.53; H, 3.15; N, 3.10.
2-[2-(6-Iodo-1,3-benzodioxol-5-yl)ethyl]isoquinolin-1(2 H )-one (12)
Compound 12 was prepared from 11 (1.09 g, 2.51 mmol) by the same procedure as described above for the preparation of 10 from 9.
Yield: 819 mg (78%); mp 165-167 ˚C.
IR (CHCl3): 1651, 1626, 1599 cm-¹.
¹H NMR (200 MHz, CDCl3): δ = 3.14 (t, J = 8 Hz, 2 H), 4.15 (t, J = 8 Hz, 2 H), 5.94 (s, 2 H), 6.43 (d, J = 8 Hz, 1 H), 6.75 (s, 1 H), 6.94 (d, J = 6 Hz, 1 H), 7.24 (s, 1 H), 7.40-7.70 (m, 3 H), 8.46 (dd, J = 8, 2 Hz, 1 H).
¹³C NMR (125 MHz, CDCl3): δ = 39.6, 49.6, 87.8, 101.6, 105.9, 110.2, 118.6, 125.9, 126.1, 126.8, 127.7, 131.7, 132.1, 134.0, 137.0, 147.4, 148.7, 162.1.
Anal. Calcd for C18H14INO3: C, 51.57; H, 3.37; N, 3.34. Found: C, 51.42; H, 3.48; N, 3.29.
6-Phenethyl[1,3]dioxolo[4,5- g ]isoquinoline-5,7(6 H ,8 H )-dione (14a)
A stirring soln of Ph(CH2)2NH2 (108 mg, 0.89 mmol) and 13 (200 mg, 0.89 mmol) in 1,2-dichlorobenzene (10 mL) was refluxed at 180 ˚C for 3 h. After the mixture had cooled to r.t., it was loaded on a silica gel column [PE (removal of 1,2-dichlorobenzene), then PE-EtOAc, 4:1]; this furnished 14a as a yellow crystalline solid.
Yield: 253 mg (92%); mp 110-112 ˚C.
IR (CHCl3): 1711, 1665, 1622 cm-¹.
¹H NMR (200 MHz, CDCl3): δ = 2.84-2.96 (m, 2 H), 3.91 (s, 2 H), 4.12-4.23 (m, 2 H), 6.07 (s, 2 H), 6.65 (s, 1 H), 7.16-7.34 (m, 5 H), 7.59 (s, 1 H).
¹³C NMR (50 MHz, CDCl3): δ = 34.0, 36.4, 41.4, 102.0, 106.3, 107.8, 119.4, 126.4, 128.4, 128.9, 130.3, 138.6, 147.7, 152.5, 164.0, 169.7.
Anal. Calcd for C18H15NO4: C, 69.89; H, 4.89; N, 4.53. Found: C, 70.02; H, 4.63; N, 4.40.
6-Phenethyl[1,3]dioxolo[4,5- g ]isoquinolin-5(6 H )-one (15a)
Compound 15a was prepared from 14a (150 mg, 0.49 mmol) by the same procedure as described above for the preparation of 10 from 9.
Yield: 139 mg (98%); mp 107-109 ˚C.
IR (CHCl3): 1657, 1620, 1606 cm-¹.
¹H NMR (200 MHz, CDCl3): δ = 3.07 (t, J = 8 Hz, 2 H), 4.18 (t, J = 8 Hz, 2 H), 6.07 (s, 2 H), 6.25 (d, J = 8 Hz, 1 H), 6.70 (d, J = 8 Hz, 1 H), 6.82 (s, 1 H), 7.14-7.34 (m, 5 H), 7.80 (s, 1 H).
¹³C NMR (50 MHz, CDCl3): δ = 35.3, 51.5, 101.6, 103.6, 105.5, 105.6, 121.7, 126.5, 128.6, 128.9, 130.7, 134.3, 138.3, 147.8, 151.7, 161.2.
Anal. Calcd for C18H15NO3: C, 73.71; H, 5.15; N, 4.78. Found: C, 73.68; H, 5.11; N, 4.97.
6-(2-Bromophenethyl)[1,3]dioxolo[4,5- g ]isoquinoline-5,7(6 H ,8 H )-dione (14b)
Compound 14b was prepared from 2-BrC6H4(CH2)2NH2 (446 mg, 2.23 mmol) and 13 (500 mg, 2.23 mmol) by the same procedure as described above for the preparation of 14a from 13 and Ph(CH2)2NH2.
Yield: 814 mg (94%); mp 134-136 ˚C.
IR (CHCl3): 1709, 1665, 1657, 1649, 1618 cm-¹.
¹H NMR (200 MHz, CDCl3): δ = 3.00-3.15 (m, 2 H), 3.90 (s, 2 H), 4.15-4.30 (m, 2 H), 6.06 (s, 2 H), 6.65 (s, 1 H), 7.00-7.32 (m, 3 H), 7.53 (dd, J = 8, 2 Hz, 1 H), 7.58 (s, 1 H).
¹³C NMR (50 MHz, CDCl3): δ = 34.1, 36.4, 39.6, 102.0, 106.3, 107.7, 119.3, 124.6, 127.4, 128.1, 130.2, 130.9, 132.7, 138.2, 147.6, 152.4, 163.9, 169.7.
Anal. Calcd for C18H14BrNO4: C, 55.69; H, 3.63; N, 3.61. Found: C, 55.55; H, 3.47; N, 3.80.
6-(2-Bromophenethyl)[1,3]dioxolo[4,5- g ]isoquinolin-5(6 H )-one (15b)
Compound 15b was prepared from 14b (600 mg, 1.54 mmol) by the same procedure as described above for the preparation of 10 from 9.
Yield: 563 mg (98%); mp 153-155 ˚C.
IR (CHCl3): 1655, 1618, 1605 cm-¹.
¹H NMR (200 MHz, CDCl3): δ = 3.23 (t, J = 8 Hz, 2 H), 4.22 (t, J = 8 Hz, 2 H), 6.08 (s, 2 H), 6.27 (d, J = 6 Hz, 1 H), 6.76 (d, J = 6 Hz, 1 H), 6.83 (s, 1 H), 7.04-7.21 (m, 3 H), 7.56 (d, J = 8 Hz, 1 H), 7.81 (s, 1 H).
¹³C NMR (50 MHz, CDCl3): δ = 35.3, 49.2, 101.5, 103.5, 105.3, 105.5, 121.5, 124.3, 127.6, 128.3, 130.5, 131.3, 132.7, 134.2, 137.4, 147.6, 151.5, 161.1.
Anal. Calcd for C18H14BrNO3: C, 58.08; H, 3.79; N, 3.76. Found: C, 57.94; H, 3.65; N, 3.69.
5,6,13,13a-Tetrahydro-8 H -[1,3]dioxolo[4,5- g ]isoquino[3,2- a ]isoquinolin-8-one [(±)-Gusanlung D, 1]
A soln of 10 (147 mg, 0.50 mmol) in concd HCl (5 mL) was stirred at r.t. for 48 h. The mixture was then diluted with ice water (20 mL) and extracted with EtOAc (3 × 10 mL). The combined organic layer was washed successively with 5% aq NaHCO3 (20 mL) and brine (20 mL) and dried (Na2SO4). Concentration of the organic layer in vacuo followed by purification of the residue by column chromatography (silica gel, PE-EtOAc, 4:1) gave (±)-gusanlung D (1).
Yield: 100 mg (68%); mp 194-196 ˚C [Lit. [4] 250-251 ˚C (natural), Lit. [9] 195-197 ˚C (synthetic)].
IR (CHCl3): 1647 cm-¹.
¹H NMR (500 MHz, CDCl3): δ = 2.70-2.80 (m, 1 H), 2.85-3.05 (m, 3 H), 3.18 (dd, J = 16, 4 Hz, 1 H), 4.83 (dd, J = 13, 4 Hz, 1 H), 4.90-5.00 (m, 1 H), 5.96 (s, 2 H), 6.67 (s, 1 H), 6.72 (s, 1 H), 7.24 (d, J = 8 Hz, 1 H), 7.39 (t, J = 8 Hz, 1 H), 7.46 (t, J = 8 Hz, 1 H), 8.13 (d, J = 8 Hz, 1 H).
¹³C NMR (125 MHz, CDCl3): δ = 29.7, 38.1, 38.8, 55.3, 101.1, 105.9, 108.7, 126.9, 127.3, 128.5, 128.6, 128.9, 129.1, 131.8, 137.2, 146.6, 146.8, 164.6.
Anal. Calcd for C18H15NO3: C, 73.71; H, 5.15; N, 4.78. Found: C, 73.56; H, 5.28; N, 4.81.
5,6-Dihydro-8 H -[1,3]dioxolo[4,5- g ]isoquino[3,2- a ]isoquinolin-8-one (Dehydrogusanlung D, 2)
A soln of Pd(OAc)2 (0.5 mg, 0.25 mol%) and tetramethylguanidine (1 mg, 1 mol%) in DMF (10 mL) was added to an argon-flushed flask containing 12 (335 mg, 0.80 mmol) and NaOAc (98.5 mg, 1.20 mmol), and the mixture was stirred at 120 ˚C for 20 h. After cooling to r.t., the mixture was poured into H2O (20 mL) and extracted with EtOAc (3 × 25 mL). The combined organic layer was washed with brine (20 mL) and dried (Na2SO4). Concentration of the organic layer in vacuo followed by purification of the residue by column chromatography (silica gel, PE-EtOAc, 4:1) furnished 2.
Yield: 168 mg (72%); mp 181-182 ˚C (Lit. [8] 183-184 ˚C).
IR (CHCl3): 1715, 1645, 1616 cm-¹.
¹H NMR (400 MHz, CDCl3): δ = 2.91 (t, J = 6 Hz, 2 H), 4.33 (t, J = 6 Hz, 2 H), 6.01 (s, 2 H), 6.71 (s, 1 H), 6.83 (s, 1 H), 7.25 (s, 1 H), 7.43 (t, J = 8 Hz, 1 H), 7.53 (d, J = 8 Hz, 1 H), 7.62 (t, J = 8 Hz, 1 H), 8.41 (d, J = 8 Hz, 1 H).
¹³C NMR (100 MHz, CDCl3): δ = 28.5, 39.7, 101.5, 101.9, 105.0, 107.9, 123.7, 124.6, 126.0, 126.3, 127.9, 130.3, 132.3, 136.6, 137.4, 147.4, 148.7, 162.1.
Anal. Calcd for C18H13NO3: C, 74.22; H, 4.50; N, 4.81. Found: C, 74.31; H, 4.47; N, 4.96.
5,6,14,14a-Tetrahydro-8 H -[1,3]dioxolo[4,5- g ]isoquino[2,1- b ]isoquinolin-8-one [(±)-Isogusanlung D, 3]
A soln of Bu3SnH (0.3 mL, 1.07 mmol) and AIBN (9 mg, 0.05 mmol) in benzene (5 mL) was added dropwise over 5 min to a constantly stirring, refluxing soln of 15b (200 mg, 0.53 mmol) in benzene (10 mL) under a N2 atmosphere. The mixture was refluxed for an additional 2 h. Then the mixture was cooled to r.t. and the benzene solvent was removed in vacuo. The residue thus obtained was then dissolved in MeCN (20 mL) and washed with n-hexane (3 × 25 mL). Concentration of the MeCN layer in vacuo followed by purification of the residue by column chromatography (silica gel, PE-EtOAc, 7:3) furnished pure 3 as a white crystalline solid.
Yield: 116 mg (74%); mp 157-159 ˚C.
IR (CHCl3): 1639, 1611 cm-¹.
¹H NMR (400 MHz, CDCl3): δ = 2.80-3.07 (m, 4 H), 3.14 (dd, J = 12, 4 Hz, 1 H), 4.84-5.00 (m, 2 H), 6.02 (d, J = 4 Hz, 2 H), 6.69 (s, 1 H), 7.15-7.35 (m, 4 H), 7.59 (s, 1 H).
¹³C NMR (50 MHz, CDCl3): δ = 29.6, 37.7, 38.5, 55.1, 101.4, 106.7, 108.3, 123.1, 125.8, 126.6, 126.7, 128.9, 132.8, 134.9, 135.7, 146.9, 150.4, 164.1.
Anal. Calcd for C18H15NO3: C, 73.71; H, 5.15; N, 4.78. Found: C, 73.57; H, 5.05; N, 4.66.
5,6-Dihydro-8 H -[1,3]dioxolo[4,5- g ]isoquino[2,1- b ]isoquinolin-8-one (Dehydroisogusanlung D, 4)
K2CO3 (438 mg, 3.18 mmol), TBAB (346 mg, 1.07 mmol), and Pd(OAc)2 (11 mg, 10 mol%) were added to a stirred soln of 15b (200 mg, 0.53 mmol) in DMF (10 mL) at r.t. under a N2 atmosphere. Then the mixture was heated at 120 ˚C for 24 h, before it was cooled to r.t. and diluted with EtOAc (20 mL), washed with brine, and finally dried (Na2SO4). Concentration of the organic layer in vacuo followed by purification of the residue by column chromatography (silica gel, PE-EtOAc, 7:3) furnished compound 4 as a yellow crystalline solid.
Yield: 125 mg (80%); mp 174-175 ˚C.
IR (CHCl3): 1649, 1605 cm-¹.
¹H NMR (200 MHz, CDCl3): δ = 2.95-3.05 (m, 2 H), 4.30-4.40 (m, 2 H), 6.07 (s, 2 H), 6.91 (s, 2 H), 7.20-7.40 (m, 3 H), 7.70-7.80 (m, 1 H), 7.79 (s, 1 H).
¹³C NMR (50 MHz, CDCl3): δ = 28.2, 39.3, 101.4, 102.5, 103.5, 105.3, 120.2, 124.4, 127.1, 127.7, 128.8, 129.8, 133.5, 134.8, 135.8, 147.4, 151.5, 160.9.
Anal. Calcd for C18H13NO3: C, 74.22; H, 4.50; N, 4.81. Found: C, 74.37; H, 4.42; N, 4.89.
Acknowledgement
P.B.W. thanks CSIR, New Delhi and S.E. thanks UGC, New Delhi for the awards of research fellowships. N.P.A. thanks Department of Science and Technology, New Delhi, for financial support. We thank Professor Albert Padwa for providing us the experimental details for the synthesis of (±)-1.
- 1a
Meyers AI. Tetrahedron 1992, 48: 2589 - 1b
Highsmith TK.Meyers AI. In Advances in Heterocyclic Natural Product Synthesis Vol. 1:Pearson W. JAI Press; Greenwich CT: 1990. p.95-135 - 1c
Bhakuni DS.Jain S. In The Alkaloids: Chemistry and Pharmacology Vol. 28:Brossi A. Academic Press; Orlando FL: 1986. p.95-181 - 2
Davis FA.Mohanty PK. J. Org. Chem. 2002, 67: 1290 ; and references cited therein - 3a
Meyers AI.Matulenko MA. J. Org. Chem. 1996, 61: 573 - 3b
Orito K.Miyazawa M.Kanbayashi R.Tokuda M.Suginome H. J. Org. Chem. 1999, 64: 6583 - 3c
Liu L. Synthesis 2003, 1705 - 3d
Derdau V.Snieckus V. J. Org. Chem. 2001, 66: 1992 - 4
Zhang J.-S.Le Men-Olivier L.Massiot G. Phytochemistry 1995, 39: 439 - 5
Kessar SV.Singh P.Vohra R.Kaur NP.Venugopal D. J. Org. Chem. 1992, 57: 6716 - 6a
Padwa A.Waterson AG. Tetrahedron Lett. 1998, 39: 8585 - 6b
Padwa A.Waterson AG. Tetrahedron 2000, 56: 10159 - 7
Reimann E.Grasberger F.Polborn K. Monatsh. Chem. 2003, 134: 991 - 8a
Chang J.-K.Chang N.-C. Tetrahedron 2008, 64: 3483 - 8b
Grigg R.Sridharan V.Stevenson P.Sukirthalingam S.Worakun T. Tetrahedron 1990, 46: 4003 - 9
Chrzanowska M.Dreas A.Rozwadowska MD. Tetrahedron: Asymmetry 2004, 15: 1113 - 10
Haval KP.Argade NP. J. Org. Chem. 2008, 73: 6936 ; and references cited therein - 11
Reddy PY.Kondo S.Toru T.Ueno Y. J. Org. Chem. 1997, 62: 2652 - 12
Wijnberg JBPA.Schoemaker HE.Speckamp WN. Tetrahedron 1978, 34: 179 - 13a
Comins DL.Joseph SP.Zhang Y.-M. Tetrahedron Lett. 1996, 37: 793 - 13b
Kirschbaum S.Waldmann H. J. Org. Chem. 1998, 63: 4936 - 13c
Crisp GT. Chem. Soc. Rev. 1998, 27: 427 - 14
Li S.Xie H.Zhang S.Lin Y.Xu J.Cao J. Synlett 2005, 1885 - 15a
Bruggink A.Mckillop A. Angew. Chem., Int. Ed. Engl. 1974, 13: 340 - 15b
Bruggink A.Mckillop A. Tetrahedron 1975, 31: 2607 - 16
Orito K.Satoh Y.Nishizawa H.Harada R.Tokuda M. Org. Lett. 2000, 2: 2535 - 17
Haworth RD.Perkin WH.Pink HS. J. Chem. Soc. 1925, 127: 1709
References
- 1a
Meyers AI. Tetrahedron 1992, 48: 2589 - 1b
Highsmith TK.Meyers AI. In Advances in Heterocyclic Natural Product Synthesis Vol. 1:Pearson W. JAI Press; Greenwich CT: 1990. p.95-135 - 1c
Bhakuni DS.Jain S. In The Alkaloids: Chemistry and Pharmacology Vol. 28:Brossi A. Academic Press; Orlando FL: 1986. p.95-181 - 2
Davis FA.Mohanty PK. J. Org. Chem. 2002, 67: 1290 ; and references cited therein - 3a
Meyers AI.Matulenko MA. J. Org. Chem. 1996, 61: 573 - 3b
Orito K.Miyazawa M.Kanbayashi R.Tokuda M.Suginome H. J. Org. Chem. 1999, 64: 6583 - 3c
Liu L. Synthesis 2003, 1705 - 3d
Derdau V.Snieckus V. J. Org. Chem. 2001, 66: 1992 - 4
Zhang J.-S.Le Men-Olivier L.Massiot G. Phytochemistry 1995, 39: 439 - 5
Kessar SV.Singh P.Vohra R.Kaur NP.Venugopal D. J. Org. Chem. 1992, 57: 6716 - 6a
Padwa A.Waterson AG. Tetrahedron Lett. 1998, 39: 8585 - 6b
Padwa A.Waterson AG. Tetrahedron 2000, 56: 10159 - 7
Reimann E.Grasberger F.Polborn K. Monatsh. Chem. 2003, 134: 991 - 8a
Chang J.-K.Chang N.-C. Tetrahedron 2008, 64: 3483 - 8b
Grigg R.Sridharan V.Stevenson P.Sukirthalingam S.Worakun T. Tetrahedron 1990, 46: 4003 - 9
Chrzanowska M.Dreas A.Rozwadowska MD. Tetrahedron: Asymmetry 2004, 15: 1113 - 10
Haval KP.Argade NP. J. Org. Chem. 2008, 73: 6936 ; and references cited therein - 11
Reddy PY.Kondo S.Toru T.Ueno Y. J. Org. Chem. 1997, 62: 2652 - 12
Wijnberg JBPA.Schoemaker HE.Speckamp WN. Tetrahedron 1978, 34: 179 - 13a
Comins DL.Joseph SP.Zhang Y.-M. Tetrahedron Lett. 1996, 37: 793 - 13b
Kirschbaum S.Waldmann H. J. Org. Chem. 1998, 63: 4936 - 13c
Crisp GT. Chem. Soc. Rev. 1998, 27: 427 - 14
Li S.Xie H.Zhang S.Lin Y.Xu J.Cao J. Synlett 2005, 1885 - 15a
Bruggink A.Mckillop A. Angew. Chem., Int. Ed. Engl. 1974, 13: 340 - 15b
Bruggink A.Mckillop A. Tetrahedron 1975, 31: 2607 - 16
Orito K.Satoh Y.Nishizawa H.Harada R.Tokuda M. Org. Lett. 2000, 2: 2535 - 17
Haworth RD.Perkin WH.Pink HS. J. Chem. Soc. 1925, 127: 1709
References

Scheme 1 Reagents and conditions: (i) Et2O-THF (4:1), r.t., 2 h (92%); (ii) Ac2O, NaOAc, 60 ˚C, 3 h (76%); (iii) HMDS, ZnCl2, benzene, 2.5 h (90%); (iv) (a) NaBH4, EtOH, 0 ˚C, 6 h; (b) H+/HCl, r.t., 12 h (72%); (v) concd HCl, r.t., 48 h (68%); (vi) I2, AgO2CCF3, CHCl3, r.t., 8 h (86%); (vii) (a) NaBH4, EtOH, 0 ˚C, 6 h; (b) H+/HCl, r.t., 12 h (78%); (viii) AIBN, Bu3SnH, benzene, reflux, 6 h (63%); (ix) Pd(OAc)2, tetramethylguanidine, NaOAc, DMF, 110 ˚C, 20 h (72%).

Scheme 2 Reagents and conditions: (i) Ph(CH2)2NH2 (for 14a) or 2-BrC6H4(CH2)2NH2 (for 14b), 1,2-dichlorobenzene, 180 ˚C, 3 h (92/94%); (ii) (a) NaBH4, EtOH, 0 ˚C, 6 h; (b) H+/HCl, r.t., 12 h (98%); (iii) AIBN, Bu3SnH, benzene, reflux, 2 h (80%); (iv) Pd(OAc)2, TBAB, K2CO3, DMF, 120 ˚C, 24 h (74%).